TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive Obama Plan Would Double Cancer Funding, Increase Clinical Trial Enrollment To 10%. November 7, 2008